Dr. Carl Capelouto

Dr. Carl Capelouto
Dr. Carl C. Capelouto graduated Phi Beta Kappa and magna cum laude from the University of Florida. He graduated magna cum laude and Alpha Omega Alpha from Emory University School of Medicine. He then completed his internship at Brigham and Women’s Hospital, Harvard Medical School, and completed his residency in the Harvard program of Urology. Dr. Capelouto’s areas of expertise include minimally invasive treatments of many urological conditions. He is a leader in the treatment of BPH, with a special focus on the innovative Urolift procedure. He was among the first in the Southeast to offer the UroLift procedure. He has performed over 500 outpatient radiation seed implantation procedures for prostate cancer. He performs the full spectrum of minimally invasive treatments for the prostate, kidney stones, including sound wave lithotripsy and minimally invasive treatments such as ureteroscopy and percutaneous procedures for larger stones. A major focus of his practice is the treatment of bladder conditions, including overactive bladder and urinary incontinence. Dr. Capelouto has performed over 1000 female sling procedures for stress urinary incontinence. He performs botox injections and offers nerve stimulation treatments for overactive bladder and urge incontinence. No scalpel vasectomy is offered by Dr. Capelouto and he has performed over 4000 of these procedures. A graduate of the Emory University School of Medicine, he completed his general surgery and urology training at the Harvard Program in Urology in Boston, Massachusetts. He is a member of the American Urological Association, Southeastern Urological Association, and Atlanta Urological Association. He is also a Center of Excellence (COE) for the Urolift procedure and an instructor of this for other urologists. Atlanta magazine has named him a Top Doctor for seven consecutive years. Dr. Capelouto, a native of Tallahassee, Florida, also enjoys photography.
Medical School:

Emory University


Harvard University


University of Florida

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only